Should SGLT-2 Inhibitors be Withheld in the Hospital Setting Due to Increasing Prevalence of Euglycemic DKA

Authors

Raja Hamsa Chitturi, HCA HealthcareFollow
Franklin Hernandez
Charmaine Butt
Karthikram Komanduri, HCA HealthcareFollow
Mitra Chandan, HCA HealthcareFollow

Files

Division

North Florida

Hospital

HCA Florida Ocala Hospital

Specialty

Internal Medicine

Document Type

Poster

Publication Date

2025

Keywords

SGLT-2, Euglycemic DKA

Disciplines

Endocrine System Diseases | Internal Medicine | Medicine and Health Sciences

Original Publisher

HCA Healthcare Graduate Medical Education

Recommended Citation

Chitturi, Raja Hamsa; Hernandez, Franklin; Butt, Charmaine; Komanduri, Karthikram; and Chandan, Mitra, "Should SGLT-2 Inhibitors be Withheld in the Hospital Setting Due to Increasing Prevalence of Euglycemic DKA" (2025). North Florida Division GME Research Day 2025. 14.
https://scholarlycommons.hcahealthcare.com/northflorida2025/14